-
Article type: Cover
2005Volume 59Issue 5.6 Pages
Cover5-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
App35-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
App36-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Index
2005Volume 59Issue 5.6 Pages
Toc9-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Index
2005Volume 59Issue 5.6 Pages
Toc10-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Eijiro Jimi
Article type: Article
2005Volume 59Issue 5.6 Pages
199-209
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
Osteoclasts are multinucleated giant cells that play a critical role in bone resorption. It has been proposed that osteoblasts or bone marrow stromal cells are involved in osteoclastogenesis through a mechanism involving cell-to-cell contact with osteoclast precursors. This hypothesis was proved by the discovery of a new member of the TNF ligand family, receptor activator of nuclear factor-κB ligand (RANKL). Osteoclast precursors that express RANK, a TNF receptor family member, recognize RANKL and differentiate into osteoclast in the presence of macrophage colony-stimulating factor (M-CSF). The in vivo significance of RANKL-RANK signaling pathway has been verified by the observations that targeting disruption of either gene in mice results in severe osteopetrosis and a total lack of osteoclasts. Various pathological conditions which lead to excessive bone loss, such as rheumatoid arthritis, periodontal diseases and bone cancer have been shown to be influenced by cellular components e.g., T lymphocytes as well as by soluble factors produced by infiltrating lymphocytes. The term of "osteoimmunology" is an emerging concept that proposes that certain regulatory molecules link between bone metabolism and the immune system. For example, RANKL selectively induces NFATc1 expression via Ca^<2+> oscillations that lead to calcineurin-mediated activation of NFATc1, and therefore triggers a sustained NFATc1-dependent transcriptional program during osteoclast differentiation. NFATc1-deficient embryonic stem cells fail to differentiate into osteoclasts in response to RANKL stimulation, and that overexpression of NFATc1 causes precursor cells to undergo efficient differentiation without RANKL signaling. Thus, NFATc1 may represent a master regulator of terminal differentiation of osteoclasts. Another key molecule in this link between bone and immune responses is the transcription factor NF-κB. The targeting disruption of NF-κB p50/p52 was the first genetic model to reveal a direct link, but subsequently studies on IKK α and NIK deficient mice have further strengthened the evidence for this cross-talk. We have recently demonstrated that the NBD peptide, which selectively inhibits NF-κB activation can also efficiently inhibit osteoclastogenesis. It is now well accepted that NF-κB plays an essential role for osteoclast differentiation, however the molecular mechanism how does NF-κB regulate osteoclast differentiation remains unclear. It is still important to identify the target genes of NF-κB and define the molecular mechanisms through which NF-κB regulates osteoclast differentiation.
View full abstract
-
Mari Yoshida, Junya Yano, Yoko Fujimoto, Chiaki Kitamura, Takahiko Mor ...
Article type: Article
2005Volume 59Issue 5.6 Pages
210-214
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
It is generally accepted that the use of the critical pathway in the healthcare system facilitates the standardization of medical and dental practices, and several studies show that the use of critical pathways can improve the quality of care. However, there are no reports about the critical pathway for oral care including plaque control instruction by a dental hygienist. Here we examined the relationship between times of visiting a hospital for teeth brushing instruction by a dental hygienist and change of plaque control record (PCR). A total of 100 patients were instructed teeth brushing method by a dental hygienist, and visiting times, in which PCR less than 20% was gained, was examined. More than 90% of patients achieved less than 20% PCR by the third visit. During the maintenance period after the PCR reduced less than 20%, the patients, who needed only the one visit to achieve PCR less than 20%, tended to keep less than 20%, while the other patients, who needed 2 or more visits, tend to increase the PCR more than 20%. These results provide insights into making the critical pathway for plague control instruction by a dental hygienist.
View full abstract
-
Masaaki Kodama, Manabu Habu, Soichi Hirasima, Kazuhiro Tominaga, Hiros ...
Article type: Article
2005Volume 59Issue 5.6 Pages
215-220
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
Solitary intraosseous neurofibroma of the mandible is rare. The patient was 29-year-old man with swelling of the right mandible. Orthopantomographic and computed tomographic examination showed a radiolucent, well-circumscribed lesion of the right body of the mandible. Under general anesthesia, the tumor was surgically removed. The inferior alveolar nerve was in contact with the tumor, but we separated and preserved the nerve during surgery. Microscopic examination of the tumor showed spindle-shaped cells intermingled with a fibrillar stroma. Some tumor cells showed positive reaction for S-100 protein. Patient had no other signs of von Recklinghausen's disease and no familial history. Final diagnosis was a solitary intraosseous neurofibroma of the mandible. About five years have passed since the operation, there has been no recurrence of the tumor.
View full abstract
-
Takashi Uekubo
Article type: Article
2005Volume 59Issue 5.6 Pages
221-222
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Jun Mitsui
Article type: Article
2005Volume 59Issue 5.6 Pages
222-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Kentaro Ono
Article type: Article
2005Volume 59Issue 5.6 Pages
222-223
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Noritaka Yahara
Article type: Article
2005Volume 59Issue 5.6 Pages
223-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
224-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Index
2005Volume 59Issue 5.6 Pages
_1_-_2_
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
App37-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
App38-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
App39-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
App40-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
App41-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
App42-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
App43-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS
-
Article type: Appendix
2005Volume 59Issue 5.6 Pages
App44-
Published: December 25, 2005
Released on J-STAGE: December 20, 2017
JOURNAL
FREE ACCESS